Systematic Characterization of Clinically Actionable Antibody-Drug Targets Across Solid Tumors to Advance Precision Oncology
Crossref REST API · Indexed academic record · Source published: Wed Nov 18 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Indexed here: Wed Nov 18 2026 15:09:25 GMT+0000 (Coordinated Universal Time)
Saved source excerpt
Abstract The rapid expansion of antibody therapeutics is shifting the clinical bottleneck from drug availability to precise patient selection. We systematically characterize 87 clinically actionable tumor-associated antigens across solid tumors by integrating transcriptomic, proteomic, spatial, and single-cell profiles from more than 32,000 specimens to define expression prevalence, intratumoral h
This is a cited excerpt from the source. Read the original link for the complete text. Automated indexing and topic classification do not constitute fact verification.